Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial |
| |
| Authors: | Christopher C. Parker,Robert E. Coleman,Oliver Sartor,Nicholas J. Vogelzang,David Bottomley,Daniel Heinrich,Svein I. Helle,Joe M. O&#x Sullivan,Sophie D. Foss?,Ale? Chodacki,Pawe? Wiechno,John Logue,Mihalj Seke,Anders Widmark,Dag Clement Johannessen,Peter Hoskin,Nicholas D. James,Arne Solberg,Sten Nilsson |
| |
| Affiliation: | 1. The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK;2. University of Sheffield, Weston Park Hospital, Sheffield, UK;3. Tulane Cancer Center, New Orleans, LA, USA;4. Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA;5. St James''s University Hospital, Leeds, UK;6. Akershus University Hospital, Lørenskog, Norway;g. Haukeland University Hospital, Bergen, Norway;h. Centre for Cancer Research and Cell Biology, Queen''s University, Belfast, UK;i. Radiumhospitalet, Oslo, Norway;j. Hospital Kochova, Chomutov, Czech Republic;k. Centrum Onkologii—Instytut im Sklodowskiej—Curie, Warsaw, Poland;l. Christie Hospital, Manchester, UK;m. Centrallasarettet Växjö, Växjö, Sweden;n. Umeå University, Umeå, Sweden;o. Ullevål University Hospital, Oslo, Norway;p. Mount Vernon Hospital Cancer Centre, Middlesex, UK;q. Cancer Centre, University Hospitals Birmingham NHS Trust, Birmingham, UK;r. St Olavs Hospital, Trondheim, Norway;s. Clatterbridge Center for Oncology, Wirral, UK;t. Jessenius School of Medicine, Comenius University, University Hospital, Martin, Slovakia;u. Department of Urology, Marien Hospital Herne, Ruhr—University Bochum, Herne, Germany;v. Gemeinschaftspraxis, Berlin, Germany;w. Hospital das Clínicas, Faculdade de Medicina da USP, Instituto do Câncer do Estado de São Paulo, Brazil;x. Länssjukhuset Sundsvall-Härnösand County Hospital, Sundsvall, Sweden;y. Umeå University Hospital, Umeå, Sweden;z. Norwegian Radium Hospital Oslo, Norway;11. Faculty of Medicine, University of Oslo, Oslo, Norway;22. Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA;33. Bayer AS (formerly Algeta ASA), Oslo, Norway;44. Karolinska University Hospital, Stockholm, Sweden |
| |
| Abstract: | |
| |
| Keywords: | ALSYMPCA Bone metastases Castration-resistant prostate cancer Long-term safety Radium-223 Follow-up |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
